Celldex Therapeutics, Inc.

Executive Director, Managed Markets - National and Key Accounts (Remote)

Hampton, NJ, US$233,631-$303,417Posted 16 days ago

Job Description

About Celldex

Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. We have built a culture where innovative and talented people thrive—focusing a significant effort on attracting and retaining passionate and motivated employees who want to play a role in helping people with serious health conditions and who see this effort as personally rewarding. In our highly entrepreneurial environment, employees are empowered and the opportunity for professional development occurs every day.

Celldex is now entering an exciting new chapter – building a commercial team to launch barzolvolimab - the most advanced anti-KIT therapy in pivotal development that has the potential to redefine treatment for multiple allergy and dermatological diseases with Phase 3 studies in CSU, ColdU, SD and phase 2 studies in AD. We’re looking for curious, driven builders who can connect their day-to-day work to enterprise-level impact, *endlessly prioritize what matters most*, and deliver on their commitments with *urgency and ownership.* If you’re energized by building something meaningful, excited to grow personally and professionally, and motivated to create lasting impact in a fast-moving, entrepreneurial environment, we’d love to meet you.

Ready to make an impact? Learn more about joining the Celldex Team today! Overview:

Celldex is seeking an accomplished market access leader to serve as Executive Director, National and Key Accounts, reporting to the Vice President, Managed Markets. This individual will lead the national and regional payer account organization responsible for securing and optimizing access for barzolvolimab, Celldex's investigational therapy in development for chronic spontaneous urticaria (CSU), s

Apply for this role

Keep looking

Similar Remote Executive Jobs